Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2013
12/04/2013CN103416312A Plants as functional siRNA vehicles and preparation methods and uses thereof
12/04/2013CN103416311A Plants as functional microRNA vehicles and preparation methods and uses thereof
12/04/2013CN102961450B Traditional Chinese medicine composition for treating prosopalgia
12/04/2013CN102895571B Chinese medicinal preparation for treating insomnia, method for preparing Chinese medicinal preparation for treating insomnia and application of Chinese medicinal preparation for treating insomnia
12/04/2013CN102805841B Medicament for treating adverse reaction caused by anesthetics
12/04/2013CN102805728B Propofol fat emulsion injection and preparation method thereof
12/04/2013CN102784279B Method for preparing traditional Chinese medicine for treating insomnia caused by constipation malnutrition
12/04/2013CN102716307B Prepared common monkshood daughter root Chinese medicinal preparation for treating hypersomnia and preparation method thereof
12/04/2013CN102698095B Uncaria Chinese herbal preparation for curing headache and preparation method of same
12/04/2013CN102671139B Medicament for treating depressive neurosis
12/04/2013CN102670952B Medicine for treating insomnia
12/04/2013CN102670920B Good-health traditional Chinese medicine preparation with improved stability
12/04/2013CN102660548B Preparation and application of South China sea conus textile conotoxin TxO10
12/04/2013CN102657874B A hydrogel-encapsulated lentivirus Lingo-1 RNAi complex for repairing nerve injury and a preparation method thereof
12/04/2013CN102657777B Medicament for treatment of neurasthenia
12/04/2013CN102641443B Chinese medicament for treating dizziness
12/04/2013CN102626488B Gastrodia elata medicine for treating insomnia
12/04/2013CN102614346B Deer blood nerve soothing granules and preparation method thereof
12/04/2013CN102600320B Traditional Chinese medicine for calming and promoting sleep and preparation method thereof
12/04/2013CN102512518B Chinese medicinal extract for treating diabetic peripheral neuropathy and preparation method thereof
12/04/2013CN102462672B Ramosetron transdermal patch and preparation method thereof
12/04/2013CN102424818B Caspase-1-ES cell line induced by mifepristone
12/04/2013CN102406894B Chinese medicine for treating premenstrual syndrome
12/04/2013CN102295643B 2-(pyridin-2-ylamino)-pyrido[2,3d]pyrimidin-7-ones
12/04/2013CN102188610B Chinese medicinal composition with effect of improving sleeping and preparation method thereof
12/04/2013CN102159586B C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof
12/04/2013CN102119142B Salicylamide derivatives as nicotinic alpha 7 modulators
12/04/2013CN102066343B Trisubstituted 1, 2, 4 -triazoiies as nicotinic acetylcholine receptor modulators
12/04/2013CN101925603B Modulators of cystic fibrosis transmembrane conductance regulator
12/04/2013CN101848910B 7-azaindole derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
12/04/2013CN101757130B Medicine for preventing depression, and preparation method and purpose thereof
12/04/2013CN101687043B Coated oral nicotine formulation buffered with amino acid
12/04/2013CN101622243B Sulfonamide derivative
12/04/2013CN101460222B Thioninium compounds and their use
12/04/2013CN101331132B [ (1H- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenrative disorders
12/03/2013US8598360 Apoptosis signal-regulating kinase inhibitors
12/03/2013US8598345 Substituted heteroarylamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same
12/03/2013US8598324 Anti-pathogen treatments
12/03/2013US8598221 Synergistic combination of analgesic compounds
12/03/2013US8598180 Tetrahydroindolone derivatives for treatment of neurological conditions
12/03/2013US8598171 Compositions and methods for prevention and treatment of amyloid-β peptide-related disorders
12/03/2013US8598123 Peptide analogues
12/03/2013CA2723470C Nasal administration of benzodiazepines
12/03/2013CA2603509C Crystal form of asenapine maleate
12/03/2013CA2601800C Oral drug delivery system
12/03/2013CA2570987C Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
12/03/2013CA2516660C Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
11/2013
11/28/2013WO2013177570A1 Methods of preventing or treating disease of the central nervous system using rlip76
11/28/2013WO2013177565A1 Insulin-pramlintide compositions and methods for making and using them
11/28/2013WO2013177510A1 Neuronal nicotinic receptor agonists for treating schizophrenia in patients with variants of comt gene
11/28/2013WO2013177498A1 Agonists of neuronal nicotinic acetylcholine receptor a7 subtype for use in the treatment of cognitive symptoms of schizophrenia
11/28/2013WO2013177494A1 Agonists of neuronal nicotinic acetylcholine receptor a7 subtype for use in the treatment of cognitive symptoms of schizophrenia
11/28/2013WO2013177484A1 Methods of treating depression and pain
11/28/2013WO2013177367A2 Compounds and methods of use thereof for treating neurodegenerative disorders
11/28/2013WO2013177224A1 N-substituted benzamides and their use in the treatment of pain
11/28/2013WO2013177116A1 Enzymatic modification of anti-aqp4 autoantibody for modulating neuromyelitis optica
11/28/2013WO2013177104A2 Treatment for tauopathies
11/28/2013WO2013177098A1 A method for the treatment of neurologic conditions
11/28/2013WO2013177062A2 Methods for improving safety of blood-brain barrier transport
11/28/2013WO2013177024A1 QUINUCLIDINE, 1-AZABICYCLO[2.2.1]HEPTANE, 1-AZABICYCLO [3.2.1]OCTANE, and 1-AZABICYCLO[3.2.2]NONANE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
11/28/2013WO2013176885A1 Biomarkers for alzheimer's disease
11/28/2013WO2013176624A1 Microrna-320, alone or in conjunction with tpa, for treatment of acute ischemic stroke
11/28/2013WO2013176567A1 Pharmaceutical composition for the prophylaxis and treatment of psychological, behavioral and cognitive disorders
11/28/2013WO2013176503A1 Tau protein mediated neurodegenerative disease therapeutic agent
11/28/2013WO2013176220A1 Regulation of circadian rhythm
11/28/2013WO2013175469A1 Compositions and methods for the treatment and diagnosis of neurodegenerative disorders
11/28/2013WO2013175415A1 Substituted pyrimidine compounds and uses thereof
11/28/2013WO2013175315A1 Combination comprising parthenolide for use in the treatment of alzheimer's|disease and other neurodegenerative disorders
11/28/2013WO2013175215A1 Triazoles as kv3 inhibitors
11/28/2013WO2013175211A1 Hydantoin derivatives as kv3 inhibitors
11/28/2013WO2013175206A1 Novel compounds
11/28/2013WO2013175205A1 Novel Compounds
11/28/2013WO2013175053A1 Catechol o-methyltransferase activity inhibiting compounds
11/28/2013WO2013175047A1 Use of a compound of formula (i) to manufacture a medicament for treating gaucher's disease, pharmaceutical composition, a compound of formula (ib) and method for obtaining said compound
11/28/2013WO2013174882A1 Composition for treating a circadian rhythm disorder
11/28/2013WO2013174781A1 5-amino[1,4]thiazines as bace 1 inhibitors
11/28/2013WO2013174780A1 Substituted dipyridylamines and uses thereof
11/28/2013WO2013174245A1 Hederagenin derivative and preparation method and uses thereof
11/28/2013WO2013174133A1 Application of sbt in preventing and treating diabetes mellitus vasculopathy and neuropathy
11/28/2013WO2013173941A1 Peptide and the use thereof
11/28/2013WO2013150529A3 Indole, indoline derivatives, compositions comprising them and uses thereof
11/28/2013WO2013117789A3 Formylated xanthocillin analogues as neuroprotectants
11/28/2013US20130317044 Novel carboxylic acid derivatives, their preparation and use
11/28/2013US20130317013 Ep4 receptor agonist, compositions and methods thereof
11/28/2013US20130317006 Use of polymorphisms for identifying individuals at risk of developing autism
11/28/2013US20130316999 Substituted oxazolidinones and their use in the field of blood coagulation
11/28/2013US20130316953 New uses for amino acid anticonvulsants
11/28/2013US20130315949 Molecular Antigen Array
11/28/2013US20130315893 Humanized anti-il-20 antibody and uses thereof
11/28/2013US20130315863 Methods and compositions for treating flaviviridae infections
11/28/2013CA2874258A1 Peptide and the use thereof
11/27/2013EP2666767A1 Therapeutic agent for TRPV1-mediated disease
11/27/2013EP2666356A1 Rasagiline for parkinson's disease modification
11/27/2013EP2665742A2 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
11/27/2013EP2665732A1 Fused aminodihydrothiazine derivatives useful as bace inhibitors
11/27/2013EP2665731A1 Fused aminodihydrothiazine derivatives
11/27/2013EP2665478A1 Treatment of cognitive dysfunction in schizophrenia
11/27/2013EP2665477A1 Modified release compositions of epalrestat or a derivative thereof and methods for using the same
11/27/2013EP2665465A1 Orally dispersible tablet
11/27/2013CN103415532A Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 1833